Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Contract Development and Manufacturing Organizations (CDMOs） market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Contract Development and Manufacturing Organizations (CDMOs） market segmented into
Development
API production
Formulation
Based on the end-use, the global Contract Development and Manufacturing Organizations (CDMOs） market classified into
Pharmaceutical Industry
Biotechnology
Others
Based on geography, the global Contract Development and Manufacturing Organizations (CDMOs） market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS (CDMOS） INDUSTRY
2.1 Summary about Contract Development and Manufacturing Organizations (CDMOs） Industry
2.2 Contract Development and Manufacturing Organizations (CDMOs） Market Trends
2.2.1 Contract Development and Manufacturing Organizations (CDMOs） Production & Consumption Trends
2.2.2 Contract Development and Manufacturing Organizations (CDMOs） Demand Structure Trends
2.3 Contract Development and Manufacturing Organizations (CDMOs） Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Development
4.2.2 API production
4.2.3 Formulation
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pharmaceutical Industry
4.3.2 Biotechnology
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Development
5.2.2 API production
5.2.3 Formulation
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pharmaceutical Industry
5.3.2 Biotechnology
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Development
6.2.2 API production
6.2.3 Formulation
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pharmaceutical Industry
6.3.2 Biotechnology
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Development
7.2.2 API production
7.2.3 Formulation
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pharmaceutical Industry
7.3.2 Biotechnology
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Development
8.2.2 API production
8.2.3 Formulation
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pharmaceutical Industry
8.3.2 Biotechnology
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Development
9.2.2 API production
9.2.3 Formulation
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pharmaceutical Industry
9.3.2 Biotechnology
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Recipharm
10.1.2 AMRI3
10.1.3 Patheon
10.1.4 Aenova
10.1.5 Catalent
10.1.6 Amatsigroup
10.1.7 WuXi PharmaTech
10.1.8 Strides Shasun
10.1.9 Piramal
10.1.10 Siegfried
10.2 Contract Development and Manufacturing Organizations (CDMOs） Sales Date of Major Players (2017-2020e)
10.2.1 Recipharm
10.2.2 AMRI3
10.2.3 Patheon
10.2.4 Aenova
10.2.5 Catalent
10.2.6 Amatsigroup
10.2.7 WuXi PharmaTech
10.2.8 Strides Shasun
10.2.9 Piramal
10.2.10 Siegfried
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Contract Development and Manufacturing Organizations (CDMOs） Product Type Overview
2.Table Contract Development and Manufacturing Organizations (CDMOs） Product Type Market Share List
3.Table Contract Development and Manufacturing Organizations (CDMOs） Product Type of Major Players
4.Table Brief Introduction of Recipharm
5.Table Brief Introduction of AMRI3
6.Table Brief Introduction of Patheon
7.Table Brief Introduction of Aenova
8.Table Brief Introduction of Catalent
9.Table Brief Introduction of Amatsigroup
10.Table Brief Introduction of WuXi PharmaTech
11.Table Brief Introduction of Strides Shasun
12.Table Brief Introduction of Piramal
13.Table Brief Introduction of Siegfried
14.Table Products & Services of Recipharm
15.Table Products & Services of AMRI3
16.Table Products & Services of Patheon
17.Table Products & Services of Aenova
18.Table Products & Services of Catalent
19.Table Products & Services of Amatsigroup
20.Table Products & Services of WuXi PharmaTech
21.Table Products & Services of Strides Shasun
22.Table Products & Services of Piramal
23.Table Products & Services of Siegfried
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Contract Development and Manufacturing Organizations (CDMOs） Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Contract Development and Manufacturing Organizations (CDMOs） Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Contract Development and Manufacturing Organizations (CDMOs） Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Contract Development and Manufacturing Organizations (CDMOs） Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Contract Development and Manufacturing Organizations (CDMOs） Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Development Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure API production Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Formulation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Pharmaceutical Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Biotechnology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Development Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure API production Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Formulation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Pharmaceutical Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Biotechnology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Development Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure API production Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Formulation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Pharmaceutical Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Biotechnology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Development Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure API production Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Formulation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Pharmaceutical Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Biotechnology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Development Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure API production Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Formulation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Pharmaceutical Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Biotechnology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Development Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure API production Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Formulation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Pharmaceutical Industry Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Biotechnology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Contract Development and Manufacturing Organizations (CDMOs） Sales Revenue (Million USD) of Recipharm 2017-2020e
72.Figure Contract Development and Manufacturing Organi
